Skip to content
Industry
This is research, not advice. We’re not SEBI-registered.

Envista Holdings share price today

Envista Holdings Corporation · NVST · Healthcare · Medical Instruments & Supplies · price as of the 4 November 2026 close, updated every trading day · results updated weekly · All US stock lists

Envista Holdings share price: $27.19 at the close on 4 November 2026, +39.8% in a year.

MixedBusiness trend from fewer quarters than usual
$27.19Price +39.8% in a year
7.1×P/E over 4.3 years
$731 MRevenue (Jul 2026) +7.1% on a year ago
$53.7 MProfit (Jul 2026) +103.4% on a year ago
10.4%Operating margin +3.0 points on a year ago
2%ROE FY25
8.7%ROIC against a 7.5% cost of capital: +1.2 points

Envista Holdings Corporation's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer.

Biggest thing to watch: the price has already been rising for 1 weeks, so timing is the risk more than the business.

The price has been rising for 1 weeks. Over the last four quarters, results have been improving, with profit +103.4% on a year earlier, and 130% of the last 3 years' profit came in as cash. What will decide it: the next one or two quarters of results.

What is the Envista Holdings share price today?

Envista Holdings Corporation's share price was $27.19 at the close on 4 November 2026. It has been rising for 1 week. That is 5.6% above its average price over the last 200 trading days. In the last 52 weeks it traded between $19 and $29, and at that close it sat 79% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Envista Holdings Corporation is in stage 2. The phase helps read everything below.

Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 8 weeks running.

1Y

Nov 2026: $27.19, 5.6% above its 200-day average. The price has been rising for 1 week.

  • Price $27.19
  • 50-day avg $24.49
  • 200-day avg $25.75
Nov 2026: $27.19, 5.6% above its 200-day average. The price has been rising for 1 week.
WeekPrice50-day avg200-day avg
31 Oct 2025$20.35$20.53$19.25
7 Nov 2025$19.45$20.39$19.24
14 Nov 2025$19.40$20.30$19.20
21 Nov 2025$19.89$20.11$19.16
28 Nov 2025$20.90$20.09$19.16
5 Dec 2025$20.23$20.06$19.12
12 Dec 2025$21.97$20.16$19.14
19 Dec 2025$22.28$20.32$19.22
26 Dec 2025$21.99$20.54$19.32
2 Jan 2026$21.69$20.68$19.42
9 Jan 2026$23.63$20.98$19.57
16 Jan 2026$25.24$21.38$19.74
23 Jan 2026$23.84$21.74$19.90
30 Jan 2026$23.47$22.15$20.11
6 Feb 2026$29.10$22.68$20.35
13 Feb 2026$28.97$23.55$20.69
20 Feb 2026$29.12$24.22$20.93
27 Feb 2026$29.21$24.98$21.23
6 Mar 2026$26.86$25.59$21.48
13 Mar 2026$24.61$25.98$21.70
20 Mar 2026$24.89$26.27$21.87
27 Mar 2026$24.60$26.48$22.04
2 Apr 2026$25.81$26.53$22.17
10 Apr 2026$26.39$26.73$22.35
17 Apr 2026$27.84$27.12$22.54
24 Apr 2026$26.80$26.97$22.72
1 May 2026$26.33$26.74$22.87
8 May 2026$24.24$26.36$23.01
15 May 2026$23.22$25.88$23.10
22 May 2026$23.43$25.59$23.18
29 May 2026$23.55$25.45$23.25
5 Jun 2026$23.10$25.18$23.30
12 Jun 2026$24.60$25.08$23.38
18 Jun 2026$25.91$25.02$23.46
26 Jun 2026$26.96$24.94$23.59
2 Jul 2026$27.63$24.90$23.71
10 Jul 2026$25.91$24.86$23.84
17 Jul 2026$26.74$24.91$24.00
24 Jul 2026$26.33$25.08$24.14
31 Jul 2026$27.31$25.48$24.33
7 Aug 2026$28.15$25.91$24.54
14 Aug 2026$28.07$26.43$24.74
21 Aug 2026$27.20$26.81$24.92
28 Aug 2026$27.13$27.08$25.11
4 Sep 2026$27.28$27.22$25.30
11 Sep 2026$25.55$27.16$25.44
18 Sep 2026$23.35$26.94$25.53
25 Sep 2026$23.95$26.69$25.62
2 Oct 2026$23.46$26.37$25.66
9 Oct 2026$23.00$25.96$25.69
16 Oct 2026$22.90$25.48$25.71
23 Oct 2026$23.60$24.97$25.73
30 Oct 2026$23.51$24.60$25.74
4 Nov 2026$27.19$24.49$25.75
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 1-year window.

3Y

Nov 2026: $27.19, 5.6% above its 200-day average. The price has been rising for 1 week.

  • Price $27.19
  • 50-day avg $24.49
  • 200-day avg $25.75
Nov 2026: $27.19, 5.6% above its 200-day average. The price has been rising for 1 week.
WeekPrice50-day avg200-day avg
3 Nov 2023$22.10$27.34$33.95
10 Nov 2023$21.57$26.23$33.55
17 Nov 2023$23.45$25.38$33.13
24 Nov 2023$24.10$24.91$32.79
1 Dec 2023$23.90$24.40$32.37
8 Dec 2023$23.45$23.97$32.00
15 Dec 2023$23.85$23.61$31.63
22 Dec 2023$24.19$23.45$31.26
29 Dec 2023$24.06$23.41$30.99
5 Jan 2024$23.38$23.31$30.69
12 Jan 2024$24.19$23.42$30.35
19 Jan 2024$23.70$23.55$30.03
26 Jan 2024$24.37$23.82$29.66
2 Feb 2024$23.76$23.90$29.31
9 Feb 2024$21.94$23.85$28.93
16 Feb 2024$22.53$23.74$28.54
23 Feb 2024$22.65$23.68$28.28
1 Mar 2024$20.92$23.44$27.96
8 Mar 2024$21.23$23.11$27.61
15 Mar 2024$21.36$22.86$27.31
22 Mar 2024$21.32$22.58$27.04
28 Mar 2024$21.38$22.36$26.81
5 Apr 2024$20.46$22.01$26.50
12 Apr 2024$19.18$21.61$26.16
19 Apr 2024$19.96$21.18$25.81
26 Apr 2024$20.39$20.97$25.46
3 May 2024$19.00$20.69$25.08
10 May 2024$18.54$20.43$24.68
17 May 2024$18.53$20.24$24.29
24 May 2024$18.25$19.91$23.89
31 May 2024$19.36$19.68$23.60
7 Jun 2024$18.25$19.41$23.25
14 Jun 2024$17.67$19.14$22.89
21 Jun 2024$17.41$18.88$22.59
28 Jun 2024$16.63$18.57$22.24
5 Jul 2024$16.41$18.28$21.98
12 Jul 2024$16.04$17.88$21.68
19 Jul 2024$16.57$17.61$21.40
26 Jul 2024$16.31$17.34$21.15
2 Aug 2024$16.66$17.16$20.94
9 Aug 2024$16.18$16.92$20.72
16 Aug 2024$17.91$16.77$20.55
23 Aug 2024$18.70$16.76$20.45
30 Aug 2024$18.26$16.87$20.37
6 Sep 2024$17.44$16.94$20.26
13 Sep 2024$19.41$17.10$20.11
20 Sep 2024$19.00$17.38$20.01
27 Sep 2024$19.76$17.64$19.90
4 Oct 2024$18.83$17.92$19.79
11 Oct 2024$18.13$18.06$19.63
18 Oct 2024$18.88$18.28$19.49
25 Oct 2024$18.89$18.47$19.35
1 Nov 2024$20.94$18.65$19.25
8 Nov 2024$20.39$18.92$19.18
15 Nov 2024$20.57$19.20$19.09
22 Nov 2024$21.48$19.48$19.02
29 Nov 2024$22.29$19.73$19.02
6 Dec 2024$19.89$19.93$18.97
13 Dec 2024$19.47$20.00$18.94
20 Dec 2024$18.70$20.05$18.88
27 Dec 2024$19.24$20.14$18.84
3 Jan 2025$19.03$20.18$18.79
10 Jan 2025$18.58$20.20$18.75
17 Jan 2025$19.83$20.09$18.70
24 Jan 2025$21.45$20.08$18.72
31 Jan 2025$20.52$20.17$18.75
7 Feb 2025$21.25$20.16$18.77
14 Feb 2025$21.62$20.07$18.80
21 Feb 2025$20.87$20.14$18.84
28 Feb 2025$19.98$20.19$18.88
7 Mar 2025$18.43$20.16$18.86
14 Mar 2025$16.65$19.93$18.83
21 Mar 2025$16.66$19.69$18.79
28 Mar 2025$16.97$19.55$18.76
4 Apr 2025$15.48$19.18$18.73
11 Apr 2025$15.46$18.58$18.70
17 Apr 2025$15.18$18.17$18.68
25 Apr 2025$15.94$17.60$18.66
2 May 2025$16.99$17.06$18.66
9 May 2025$17.59$16.70$18.67
16 May 2025$18.27$16.66$18.72
23 May 2025$16.72$16.65$18.74
30 May 2025$18.27$16.76$18.78
6 Jun 2025$18.73$16.90$18.80
13 Jun 2025$18.45$17.06$18.82
20 Jun 2025$18.89$17.32$18.83
27 Jun 2025$19.67$17.69$18.87
3 Jul 2025$20.39$18.09$18.91
11 Jul 2025$20.20$18.51$18.94
18 Jul 2025$19.51$18.84$18.96
25 Jul 2025$20.80$19.08$18.99
1 Aug 2025$20.83$19.30$19.04
8 Aug 2025$20.24$19.58$19.09
15 Aug 2025$20.64$19.81$19.13
22 Aug 2025$21.72$20.01$19.16
29 Aug 2025$21.18$20.26$19.16
5 Sep 2025$21.31$20.40$19.17
12 Sep 2025$21.01$20.52$19.18
19 Sep 2025$20.93$20.60$19.15
26 Sep 2025$20.35$20.66$19.14
3 Oct 2025$20.85$20.70$19.15
10 Oct 2025$19.06$20.71$19.19
17 Oct 2025$19.96$20.64$19.20
24 Oct 2025$20.36$20.58$19.22
31 Oct 2025$20.35$20.53$19.25
7 Nov 2025$19.45$20.39$19.24
14 Nov 2025$19.40$20.30$19.20
21 Nov 2025$19.89$20.11$19.16
28 Nov 2025$20.90$20.09$19.16
5 Dec 2025$20.23$20.06$19.12
12 Dec 2025$21.97$20.16$19.14
19 Dec 2025$22.28$20.32$19.22
26 Dec 2025$21.99$20.54$19.32
2 Jan 2026$21.69$20.68$19.42
9 Jan 2026$23.63$20.98$19.57
16 Jan 2026$25.24$21.38$19.74
23 Jan 2026$23.84$21.74$19.90
30 Jan 2026$23.47$22.15$20.11
6 Feb 2026$29.10$22.68$20.35
13 Feb 2026$28.97$23.55$20.69
20 Feb 2026$29.12$24.22$20.93
27 Feb 2026$29.21$24.98$21.23
6 Mar 2026$26.86$25.59$21.48
13 Mar 2026$24.61$25.98$21.70
20 Mar 2026$24.89$26.27$21.87
27 Mar 2026$24.60$26.48$22.04
2 Apr 2026$25.81$26.53$22.17
10 Apr 2026$26.39$26.73$22.35
17 Apr 2026$27.84$27.12$22.54
24 Apr 2026$26.80$26.97$22.72
1 May 2026$26.33$26.74$22.87
8 May 2026$24.24$26.36$23.01
15 May 2026$23.22$25.88$23.10
22 May 2026$23.43$25.59$23.18
29 May 2026$23.55$25.45$23.25
5 Jun 2026$23.10$25.18$23.30
12 Jun 2026$24.60$25.08$23.38
18 Jun 2026$25.91$25.02$23.46
26 Jun 2026$26.96$24.94$23.59
2 Jul 2026$27.63$24.90$23.71
10 Jul 2026$25.91$24.86$23.84
17 Jul 2026$26.74$24.91$24.00
24 Jul 2026$26.33$25.08$24.14
31 Jul 2026$27.31$25.48$24.33
7 Aug 2026$28.15$25.91$24.54
14 Aug 2026$28.07$26.43$24.74
21 Aug 2026$27.20$26.81$24.92
28 Aug 2026$27.13$27.08$25.11
4 Sep 2026$27.28$27.22$25.30
11 Sep 2026$25.55$27.16$25.44
18 Sep 2026$23.35$26.94$25.53
25 Sep 2026$23.95$26.69$25.62
2 Oct 2026$23.46$26.37$25.66
9 Oct 2026$23.00$25.96$25.69
16 Oct 2026$22.90$25.48$25.71
23 Oct 2026$23.60$24.97$25.73
30 Oct 2026$23.51$24.60$25.74
4 Nov 2026$27.19$24.49$25.75
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 3-year window.

5Y

Nov 2026: $27.19, 5.6% above its 200-day average. The price has been rising for 1 week.

  • Price $27.19
  • 50-day avg $24.49
  • 200-day avg $25.75
Nov 2026: $27.19, 5.6% above its 200-day average. The price has been rising for 1 week.
WeekPrice50-day avg200-day avg
29 Oct 2021$39.10$41.27$41.35
12 Nov 2021$43.30$41.28$41.66
26 Nov 2021$40.08$41.05$41.84
10 Dec 2021$41.11$40.58$41.91
23 Dec 2021$45.70$40.82$42.03
7 Jan 2022$44.42$42.10$42.25
21 Jan 2022$42.88$42.73$42.39
4 Feb 2022$42.88$42.77$42.42
18 Feb 2022$47.92$44.10$42.55
4 Mar 2022$46.42$45.30$42.68
18 Mar 2022$49.95$45.56$42.83
1 Apr 2022$48.10$46.51$43.15
14 Apr 2022$45.84$47.15$43.28
29 Apr 2022$39.62$46.66$43.28
13 May 2022$41.75$45.51$43.30
27 May 2022$42.99$44.70$43.34
10 Jun 2022$40.20$43.37$43.41
24 Jun 2022$38.39$41.56$43.14
8 Jul 2022$39.07$40.54$42.95
22 Jul 2022$39.28$39.98$42.78
5 Aug 2022$41.07$39.64$42.83
19 Aug 2022$38.54$39.15$42.90
2 Sep 2022$35.77$39.04$42.61
16 Sep 2022$34.30$38.63$42.39
30 Sep 2022$32.81$37.61$42.07
14 Oct 2022$32.83$36.29$41.58
28 Oct 2022$33.24$34.88$41.02
11 Nov 2022$37.99$34.38$40.57
25 Nov 2022$37.09$34.44$40.28
9 Dec 2022$32.84$34.46$39.60
23 Dec 2022$33.05$34.40$38.91
6 Jan 2023$32.83$34.37$38.33
20 Jan 2023$36.82$34.62$37.70
3 Feb 2023$41.21$35.09$37.34
17 Feb 2023$38.48$36.05$37.25
3 Mar 2023$39.69$37.02$37.08
17 Mar 2023$37.60$38.02$36.87
31 Mar 2023$40.88$38.88$36.74
14 Apr 2023$37.66$39.01$36.81
28 Apr 2023$38.49$38.50$36.80
12 May 2023$33.05$37.88$36.59
26 May 2023$33.27$37.07$36.28
9 Jun 2023$31.79$36.05$35.98
23 Jun 2023$33.50$34.93$35.81
7 Jul 2023$33.74$34.12$35.69
21 Jul 2023$35.35$33.74$35.74
4 Aug 2023$33.65$33.76$35.80
18 Aug 2023$32.68$33.84$35.79
1 Sep 2023$32.38$33.78$35.66
15 Sep 2023$28.87$33.15$35.36
29 Sep 2023$27.88$31.84$35.08
13 Oct 2023$24.26$30.10$34.72
27 Oct 2023$23.52$28.35$34.27
10 Nov 2023$21.57$26.23$33.55
24 Nov 2023$24.10$24.91$32.79
8 Dec 2023$23.45$23.97$32.00
22 Dec 2023$24.19$23.45$31.26
5 Jan 2024$23.38$23.31$30.69
19 Jan 2024$23.70$23.55$30.03
2 Feb 2024$23.76$23.90$29.31
16 Feb 2024$22.53$23.74$28.54
1 Mar 2024$20.92$23.44$27.96
15 Mar 2024$21.36$22.86$27.31
28 Mar 2024$21.38$22.36$26.81
12 Apr 2024$19.18$21.61$26.16
26 Apr 2024$20.39$20.97$25.46
10 May 2024$18.54$20.43$24.68
24 May 2024$18.25$19.91$23.89
7 Jun 2024$18.25$19.41$23.25
21 Jun 2024$17.41$18.88$22.59
5 Jul 2024$16.41$18.28$21.98
19 Jul 2024$16.57$17.61$21.40
2 Aug 2024$16.66$17.16$20.94
16 Aug 2024$17.91$16.77$20.55
30 Aug 2024$18.26$16.87$20.37
13 Sep 2024$19.41$17.10$20.11
27 Sep 2024$19.76$17.64$19.90
11 Oct 2024$18.13$18.06$19.63
25 Oct 2024$18.89$18.47$19.35
8 Nov 2024$20.39$18.92$19.18
22 Nov 2024$21.48$19.48$19.02
6 Dec 2024$19.89$19.93$18.97
20 Dec 2024$18.70$20.05$18.88
3 Jan 2025$19.03$20.18$18.79
17 Jan 2025$19.83$20.09$18.70
31 Jan 2025$20.52$20.17$18.75
14 Feb 2025$21.62$20.07$18.80
28 Feb 2025$19.98$20.19$18.88
14 Mar 2025$16.65$19.93$18.83
28 Mar 2025$16.97$19.55$18.76
11 Apr 2025$15.46$18.58$18.70
25 Apr 2025$15.94$17.60$18.66
9 May 2025$17.59$16.70$18.67
23 May 2025$16.72$16.65$18.74
6 Jun 2025$18.73$16.90$18.80
20 Jun 2025$18.89$17.32$18.83
3 Jul 2025$20.39$18.09$18.91
18 Jul 2025$19.51$18.84$18.96
1 Aug 2025$20.83$19.30$19.04
15 Aug 2025$20.64$19.81$19.13
29 Aug 2025$21.18$20.26$19.16
12 Sep 2025$21.01$20.52$19.18
26 Sep 2025$20.35$20.66$19.14
10 Oct 2025$19.06$20.71$19.19
24 Oct 2025$20.36$20.58$19.22
7 Nov 2025$19.45$20.39$19.24
21 Nov 2025$19.89$20.11$19.16
5 Dec 2025$20.23$20.06$19.12
19 Dec 2025$22.28$20.32$19.22
2 Jan 2026$21.69$20.68$19.42
16 Jan 2026$25.24$21.38$19.74
30 Jan 2026$23.47$22.15$20.11
13 Feb 2026$28.97$23.55$20.69
27 Feb 2026$29.21$24.98$21.23
13 Mar 2026$24.61$25.98$21.70
27 Mar 2026$24.60$26.48$22.04
10 Apr 2026$26.39$26.73$22.35
24 Apr 2026$26.80$26.97$22.72
8 May 2026$24.24$26.36$23.01
22 May 2026$23.43$25.59$23.18
5 Jun 2026$23.10$25.18$23.30
18 Jun 2026$25.91$25.02$23.46
2 Jul 2026$27.63$24.90$23.71
17 Jul 2026$26.74$24.91$24.00
31 Jul 2026$27.31$25.48$24.33
14 Aug 2026$28.07$26.43$24.74
28 Aug 2026$27.13$27.08$25.11
11 Sep 2026$25.55$27.16$25.44
25 Sep 2026$23.95$26.69$25.62
9 Oct 2026$23.00$25.96$25.69
23 Oct 2026$23.60$24.97$25.73
4 Nov 2026$27.19$24.49$25.75
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 5-year window.

Price stage: Rising from Oct 2025 to Sep 2026; Sideways from Sep 2026 to Nov 2026.

Price stage: Falling from Nov 2023 to Oct 2024; Sideways from Nov 2024 to Feb 2025; Falling from Mar 2025 to Jun 2025; Sideways from Jun 2025 to Jul 2025; Rising from Aug 2025 to Sep 2026; Sideways from Sep 2026 to Nov 2026.

Price stage: Sideways from Oct 2021 to Dec 2021; Rising from Dec 2021 to Apr 2022; Sideways from Apr 2022 to Sep 2022; Falling from Sep 2022 to Jan 2023; Sideways from Feb 2023 to Apr 2023; Falling from May 2023 to Oct 2024; Sideways from Nov 2024 to Feb 2025; Falling from Mar 2025 to Jun 2025; Sideways from Jun 2025 to Jul 2025; Rising from Aug 2025 to Sep 2026; Sideways from Sep 2026 to Nov 2026.

Week by week since 2019: did it beat the S&P 500 over the past 13 weeks?

Ahead in 149 of 360 weeks

Week by week since 2019: did it beat the S&P 500 over the past 13 weeks?
Week13-week return vs S&P 500
20 Sep 2019no S&P 500 reading
27 Sep 2019no S&P 500 reading
4 Oct 2019no S&P 500 reading
11 Oct 2019no S&P 500 reading
18 Oct 2019no S&P 500 reading
25 Oct 2019no S&P 500 reading
1 Nov 2019no S&P 500 reading
8 Nov 2019no S&P 500 reading
15 Nov 2019no S&P 500 reading
22 Nov 2019no S&P 500 reading
29 Nov 2019no S&P 500 reading
6 Dec 2019no S&P 500 reading
13 Dec 2019no S&P 500 reading
20 Dec 2019−9.2%
27 Dec 2019+3.6%
3 Jan 2020+1.1%
10 Jan 2020+5.9%
17 Jan 2020−0.1%
24 Jan 2020+5.6%
31 Jan 2020−5.2%
7 Feb 2020−6.3%
14 Feb 2020−3.0%
21 Feb 2020−6.8%
28 Feb 2020−4.0%
6 Mar 2020−13.3%
13 Mar 2020−17.4%
20 Mar 2020−29.1%
27 Mar 2020−29.0%
3 Apr 2020−34.4%
9 Apr 2020−31.2%
17 Apr 2020−32.0%
24 Apr 2020−31.8%
1 May 2020−24.2%
8 May 2020−27.4%
15 May 2020−30.5%
22 May 2020−19.7%
29 May 2020−19.4%
5 Jun 2020−3.5%
12 Jun 2020−10.0%
19 Jun 2020+38.7%
26 Jun 2020+14.5%
2 Jul 2020+39.1%
10 Jul 2020+0.9%
17 Jul 2020+13.5%
24 Jul 2020+13.4%
31 Jul 2020+0.6%
7 Aug 2020+17.9%
14 Aug 2020+32.3%
21 Aug 2020+5.1%
28 Aug 2020−2.0%
4 Sep 2020−5.0%
11 Sep 2020+18.1%
18 Sep 2020+10.5%
25 Sep 2020+11.4%
2 Oct 2020+7.9%
9 Oct 2020+22.2%
16 Oct 2020+14.8%
23 Oct 2020+16.5%
30 Oct 2020+20.8%
6 Nov 2020+12.2%
13 Nov 2020+18.6%
20 Nov 2020+22.7%
27 Nov 2020+19.6%
4 Dec 2020+27.4%
11 Dec 2020+13.9%
18 Dec 2020+22.4%
24 Dec 2020+23.6%
31 Dec 2020+25.3%
8 Jan 2021+21.8%
15 Jan 2021+24.8%
22 Jan 2021+21.6%
29 Jan 2021+21.2%
5 Feb 2021+27.3%
12 Feb 2021+25.8%
19 Feb 2021+22.4%
26 Feb 2021+26.0%
5 Mar 2021+16.5%
12 Mar 2021+24.4%
19 Mar 2021+21.3%
26 Mar 2021+19.6%
1 Apr 2021+13.9%
9 Apr 2021+13.0%
16 Apr 2021+7.8%
23 Apr 2021+11.6%
30 Apr 2021+9.0%
7 May 2021+11.8%
14 May 2021+6.0%
21 May 2021+8.5%
28 May 2021+2.8%
4 Jun 2021−1.9%
11 Jun 2021+0.4%
18 Jun 2021−3.3%
25 Jun 2021−1.0%
2 Jul 2021−2.1%
9 Jul 2021−2.7%
16 Jul 2021−7.1%
23 Jul 2021−11.4%
30 Jul 2021−5.5%
6 Aug 2021−14.3%
13 Aug 2021−18.6%
20 Aug 2021−14.3%
27 Aug 2021−9.4%
3 Sep 2021−4.2%
10 Sep 2021−7.3%
17 Sep 2021−6.9%
24 Sep 2021−5.5%
1 Oct 2021−1.4%
8 Oct 2021−8.9%
15 Oct 2021−8.8%
22 Oct 2021−8.9%
29 Oct 2021−14.0%
5 Nov 2021−0.6%
12 Nov 2021+3.4%
19 Nov 2021−2.4%
26 Nov 2021−8.0%
3 Dec 2021−10.6%
10 Dec 2021−10.2%
17 Dec 2021−7.9%
23 Dec 2021−0.4%
31 Dec 2021−4.0%
7 Jan 2022+4.7%
14 Jan 2022+15.4%
21 Jan 2022+13.1%
28 Jan 2022+12.3%
4 Feb 2022+3.2%
11 Feb 2022+13.7%
18 Feb 2022+21.2%
25 Feb 2022+25.7%
4 Mar 2022+24.4%
11 Mar 2022+20.4%
18 Mar 2022+25.4%
25 Mar 2022+12.0%
1 Apr 2022+11.4%
8 Apr 2022+7.8%
14 Apr 2022+4.8%
22 Apr 2022+3.4%
29 Apr 2022+0.1%
6 May 2022+12.9%
13 May 2022−1.9%
20 May 2022−2.0%
27 May 2022−6.3%
3 Jun 2022−2.0%
10 Jun 2022−3.6%
17 Jun 2022−11.1%
24 Jun 2022−8.6%
1 Jul 2022−2.8%
8 Jul 2022−2.1%
15 Jul 2022−3.4%
22 Jul 2022−1.7%
29 Jul 2022+2.6%
5 Aug 2022−9.0%
12 Aug 2022−6.9%
19 Aug 2022−16.6%
26 Aug 2022−12.5%
2 Sep 2022−12.7%
9 Sep 2022−10.1%
16 Sep 2022−9.0%
23 Sep 2022−4.0%
30 Sep 2022−9.9%
7 Oct 2022−8.3%
14 Oct 2022−8.2%
21 Oct 2022−8.8%
28 Oct 2022−12.7%
4 Nov 2022−7.3%
11 Nov 2022−1.8%
18 Nov 2022+1.7%
25 Nov 2022+2.1%
2 Dec 2022−6.4%
9 Dec 2022−10.1%
16 Dec 2022−3.3%
23 Dec 2022−8.7%
30 Dec 2022−4.4%
6 Jan 2023−8.1%
13 Jan 2023−2.9%
20 Jan 2023+3.4%
27 Jan 2023+11.1%
3 Feb 2023+10.2%
10 Feb 2023+2.7%
17 Feb 2023+1.7%
24 Feb 2023+4.6%
3 Mar 2023+14.7%
10 Mar 2023+15.9%
17 Mar 2023+12.4%
24 Mar 2023+12.4%
31 Mar 2023+14.4%
6 Apr 2023+11.8%
14 Apr 2023+2.2%
21 Apr 2023+1.6%
28 Apr 2023−2.1%
5 May 2023−14.3%
12 May 2023−18.1%
19 May 2023−10.8%
26 May 2023−19.0%
2 Jun 2023−22.8%
9 Jun 2023−26.5%
16 Jun 2023−23.7%
23 Jun 2023−21.9%
30 Jun 2023−25.5%
7 Jul 2023−19.5%
14 Jul 2023−15.8%
21 Jul 2023−18.9%
28 Jul 2023−19.7%
4 Aug 2023−13.1%
11 Aug 2023−7.3%
18 Aug 2023−12.0%
25 Aug 2023−7.1%
1 Sep 2023−7.2%
8 Sep 2023−9.7%
15 Sep 2023−14.6%
22 Sep 2023−16.3%
29 Sep 2023−14.0%
6 Oct 2023−19.8%
13 Oct 2023−26.9%
20 Oct 2023−23.0%
27 Oct 2023−22.1%
3 Nov 2023−31.6%
10 Nov 2023−34.2%
17 Nov 2023−31.5%
24 Nov 2023−29.3%
1 Dec 2023−27.9%
8 Dec 2023−24.8%
15 Dec 2023−23.2%
22 Dec 2023−23.1%
29 Dec 2023−24.9%
5 Jan 2024−20.3%
12 Jan 2024−10.8%
19 Jan 2024−18.9%
26 Jan 2024−15.1%
2 Feb 2024−6.2%
9 Feb 2024−12.0%
16 Feb 2024−14.7%
23 Feb 2024−17.6%
1 Mar 2024−24.2%
8 Mar 2024−20.7%
15 Mar 2024−19.1%
22 Mar 2024−21.9%
28 Mar 2024−21.2%
5 Apr 2024−23.3%
12 Apr 2024−27.9%
19 Apr 2024−18.4%
26 Apr 2024−20.6%
3 May 2024−23.5%
10 May 2024−19.4%
17 May 2024−23.7%
24 May 2024−23.7%
31 May 2024−10.3%
7 Jun 2024−18.4%
14 Jun 2024−23.7%
21 Jun 2024−22.8%
28 Jun 2024−26.3%
5 Jul 2024−26.8%
12 Jul 2024−26.0%
19 Jul 2024−27.9%
26 Jul 2024−27.1%
2 Aug 2024−16.5%
9 Aug 2024−15.1%
16 Aug 2024−8.0%
23 Aug 2024−3.7%
30 Aug 2024−12.6%
6 Sep 2024−5.6%
13 Sep 2024+6.3%
20 Sep 2024+4.8%
27 Sep 2024+13.8%
4 Oct 2024+11.4%
11 Oct 2024+9.5%
18 Oct 2024+7.5%
25 Oct 2024+9.5%
1 Nov 2024+18.5%
8 Nov 2024+13.8%
15 Nov 2024+9.2%
22 Nov 2024+8.9%
29 Nov 2024+15.2%
6 Dec 2024+1.6%
13 Dec 2024−7.2%
20 Dec 2024−5.6%
27 Dec 2024−6.8%
3 Jan 2025−2.2%
10 Jan 2025+2.3%
17 Jan 2025+2.8%
24 Jan 2025+8.6%
31 Jan 2025−7.4%
7 Feb 2025+3.8%
14 Feb 2025+1.0%
21 Feb 2025−3.6%
28 Feb 2025−9.0%
7 Mar 2025−2.1%
14 Mar 2025−7.6%
21 Mar 2025−6.3%
28 Mar 2025−5.2%
4 Apr 2025−4.0%
11 Apr 2025−8.8%
17 Apr 2025−11.5%
25 Apr 2025−16.3%
2 May 2025−11.4%
9 May 2025−11.2%
16 May 2025−13.0%
23 May 2025−16.4%
30 May 2025−7.8%
6 Jun 2025−2.4%
13 Jun 2025+4.7%
20 Jun 2025+8.0%
27 Jun 2025+5.2%
3 Jul 2025+8.0%
11 Jul 2025+13.9%
18 Jul 2025+9.3%
25 Jul 2025+14.8%
1 Aug 2025+12.9%
8 Aug 2025+2.2%
15 Aug 2025+4.7%
22 Aug 2025+18.5%
29 Aug 2025+6.5%
5 Sep 2025+5.7%
12 Sep 2025+3.8%
19 Sep 2025−0.9%
26 Sep 2025−4.2%
3 Oct 2025−4.8%
10 Oct 2025−10.4%
17 Oct 2025−3.6%
24 Oct 2025−8.4%
31 Oct 2025−12.0%
7 Nov 2025−9.2%
14 Nov 2025−10.4%
21 Nov 2025−10.6%
28 Nov 2025−7.3%
5 Dec 2025−11.0%
12 Dec 2025+0.9%
19 Dec 2025+3.9%
26 Dec 2025+3.8%
2 Jan 2026+1.9%
9 Jan 2026+17.7%
16 Jan 2026+22.3%
23 Jan 2026+15.3%
30 Jan 2026+13.9%
6 Feb 2026+46.7%
13 Feb 2026+47.9%
20 Feb 2026+41.8%
27 Feb 2026+39.4%
6 Mar 2026+34.7%
13 Mar 2026+14.9%
20 Mar 2026+16.4%
27 Mar 2026+20.0%
2 Apr 2026+23.0%
10 Apr 2026+13.8%
17 Apr 2026+7.6%
24 Apr 2026+8.8%
1 May 2026+8.0%
8 May 2026−23.5%
15 May 2026−28.3%
22 May 2026−27.7%
29 May 2026−29.7%
5 Jun 2026−23.7%
12 Jun 2026−12.0%
18 Jun 2026−11.0%
26 Jun 2026−5.4%
2 Jul 2026−6.5%
10 Jul 2026−12.9%
17 Jul 2026−8.6%
24 Jul 2026−5.3%
31 Jul 2026+0.1%
7 Aug 2026+11.3%
14 Aug 2026+15.9%
21 Aug 2026+13.4%
28 Aug 2026+13.5%
4 Sep 2026+13.7%
11 Sep 2026+0.8%
18 Sep 2026−11.9%
25 Sep 2026−17.0%
2 Oct 2026−18.4%
9 Oct 2026−14.4%
16 Oct 2026−17.0%
23 Oct 2026−13.2%
30 Oct 2026−15.1%
4 Nov 2026−2.6%
Each bar is one week, from 2019 to now (360 weeks with a reading). Green means the stock's return over the previous 13 weeks beat the S&P 500; red means it trailed. The colour is strongest at a gap of 25 percentage points or more. A gap means there is no reading for that week.

Over the last 7.1 years the share price moved −5% while the S&P 500 moved +157%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 11 September 2026. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

What dividend does Envista Holdings pay?

Envista Holdings Corporation pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes.

Which stock lists is Envista Holdings on?

Envista Holdings is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list.

Is Envista Holdings profitable?

Envista Holdings Corporation earned $53.7 M of net profit in the Jul 2026 quarter, +103.4% on the same quarter a year earlier. That is the 3rd quarter in a row of profit growth. Full-year FY25 profit was $47.0 M. Over 4 years profit has grown −39.0% a year on average. That is 7.4% of the quarter's revenue.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

The same quarter a year earlier earned $26.4 M. 3 of the last 12 reported quarters were loss-making.

FY25 profit $47.0 M, −39.0% a year over 4 years

  • Net profit $47.0 M
FY25 profit $47.0 M, −39.0% a year over 4 years
QuarterNet profit
FY21$341 M
FY22$243 M
FY23−$100 M
FY24−$1.1 B
FY25$47.0 M

Growth on a year earlier

  • Growth on a year earlier −141.2%
Growth on a year earlier
QuarterGrowth on a year earlier
FY21–
FY22−28.6%
FY23−141.2%
FY24–
FY25–
Top: net profit each year, $ B. Below: growth on the year before, %. 5-year window. A grey bar is lower than the year before.

Jul 2026: $53.7 M (+103.4% on a year earlier), the 3rd quarter in a row of growth

  • Net profit (quarterly) $53.7 M
Jul 2026: $53.7 M (+103.4% on a year earlier), the 3rd quarter in a row of growth
QuarterNet profit (quarterly)
Sep 2023$21.5 M
Dec 2023−$217 M
Mar 2024$23.6 M
Jun 2024−$1.2 B
Sep 2024$8.2 M
Dec 2024$1.2 M
Mar 2025$18.0 M
Jun 2025$26.4 M
Sep 2025−$30.3 M
Dec 2025$32.9 M
Apr 2026$38.7 M
Jul 2026$53.7 M

Growth on a year earlier

  • Growth on a year earlier 103.4%
Growth on a year earlier
QuarterGrowth on a year earlier
Sep 2023−54.8%
Dec 2023−395.8%
Mar 2024−46.1%
Jun 2024−2,318.9%
Sep 2024−61.9%
Dec 2024–
Mar 2025−23.7%
Jun 2025–
Sep 2025−469.5%
Dec 20252,641.7%
Apr 2026115%
Jul 2026103.4%
Top: net profit each quarter, $ B. Below: growth on the same quarter a year earlier, %. Last 12 quarters. A grey bar is lower than the quarter before.

Why profit moved: revenue changed +7.1% on a year earlier and the margin moved +3.0 percentage points. Most of the change came from keeping more of each sale.

On average over the last four quarters, profit changed +597.6% and revenue +12.0%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra dollar of revenue adds more to profit.

How much revenue does Envista Holdings make, and is it growing?

Envista Holdings Corporation reported $731 M of revenue in the Jul 2026 quarter, +7.1% on the same quarter a year earlier. That is the 5th quarter in a row with growth on the year before. Over 4 years it has grown 2.0% a year on average. The last full year, FY25, came in at $2.7 B.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to $2.9 B.

FY25 revenue was $2.7 B, +8.3% on the year before.

FY25 revenue $2.7 B (+8.3% on the year before), 2.0% a year over 4 years

  • Revenue $2.7 B
FY25 revenue $2.7 B (+8.3% on the year before), 2.0% a year over 4 years
QuarterRevenue
FY21$2.5 B
FY22$2.6 B
FY23$2.6 B
FY24$2.5 B
FY25$2.7 B

Growth on a year earlier

  • Growth on a year earlier 8.3%
Growth on a year earlier
QuarterGrowth on a year earlier
FY21–
FY222.4%
FY23−0.1%
FY24−2.2%
FY258.3%
Top: revenue each year, $ B. Below: growth on the year before, %. 5-year window. A grey bar is lower than the year before.

Jul 2026: $731 M (+7.1% on a year earlier), the 5th quarter in a row of growth

  • Revenue (quarterly) $731 M
Jul 2026: $731 M (+7.1% on a year earlier), the 5th quarter in a row of growth
QuarterRevenue (quarterly)
Sep 2023$631 M
Dec 2023$646 M
Mar 2024$624 M
Jun 2024$633 M
Sep 2024$601 M
Dec 2024$653 M
Mar 2025$617 M
Jun 2025$682 M
Sep 2025$670 M
Dec 2025$751 M
Apr 2026$706 M
Jul 2026$731 M

Growth on a year earlier

  • Growth on a year earlier 7.1%
Growth on a year earlier
QuarterGrowth on a year earlier
Sep 20230%
Dec 2023−2.3%
Mar 2024−0.6%
Jun 2024−4.4%
Sep 2024−4.8%
Dec 20241.1%
Mar 2025−1.1%
Jun 20257.7%
Sep 202511.5%
Dec 202515%
Apr 202614.4%
Jul 20267.1%
Top: revenue each quarter, $ M. Below: growth on the same quarter a year earlier, %. Last 12 quarters. A grey bar is lower than the quarter before.

Recent pace: the last four quarters grew +12.0% on average, against 2.0% a year over the longer run, so this year is growing faster than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +11.9%, against +6.2% a year over the last 8 quarters (accelerating).

How much of every $100 of sales does Envista Holdings keep?

Envista Holdings Corporation's operating margin was 10.4% in the Jul 2026 quarter, 3.0 percentage points higher than the same quarter a year ago. Across 5 years it has been between 5.7% and 14.8%. The latest quarter is within that range.

Operating margin is what is left from every $100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed +3.0 percentage points on the year while gross margin changed +0.7 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales.

FY25: 9.0%, within a range of 5.7% to 14.8% over 5 years

  • Operating margin 9.0%
FY25: 9.0%, within a range of 5.7% to 14.8% over 5 years
QuarterOperating margin
FY2114.8%
FY2214%
FY2312.8%
FY245.7%
FY259%

Change on the year before (points)

  • Change on the year before (points) +3.3 pts
Change on the year before (points)
QuarterChange on the year before (points)
FY21–
FY22−0.8 pts
FY23−1.2 pts
FY24−7.1 pts
FY25+3.3 pts
Operating margin each year, % (top). Below: change on the year before, in percentage points. 5-year window.

Jul 2026: operating margin 10.4% (+3.0 points on a year earlier)

  • Operating margin 10.4%
Jul 2026: operating margin 10.4% (+3.0 points on a year earlier)
QuarterOperating margin
Sep 202314.3%
Dec 202310.6%
Mar 20248.8%
Jun 20241%
Sep 20243.7%
Dec 20249.1%
Mar 20258%
Jun 20257.4%
Sep 20259.7%
Dec 202510.7%
Apr 20269.9%
Jul 202610.4%

Change on a year earlier (points)

  • Change on a year earlier (points) +3.0 pts
Change on a year earlier (points)
QuarterChange on a year earlier (points)
Sep 2023+1.0 pts
Dec 2023−9.0 pts
Mar 2024−3.4 pts
Jun 2024−13.0 pts
Sep 2024−10.6 pts
Dec 2024−1.5 pts
Mar 2025−0.8 pts
Jun 2025+6.4 pts
Sep 2025+6.0 pts
Dec 2025+1.6 pts
Apr 2026+1.9 pts
Jul 2026+3.0 pts
Top: quarterly operating margin, %. Below: change on the same quarter a year earlier, in percentage points. Last 12 quarters. Operating profit as a share of revenue, each quarter.

Is Envista Holdings' profit turning into cash?

Over the last 3 years, 130% of Envista Holdings Corporation's reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $276 M of operating cash against $47.0 M of profit. After $45.3 M of spending on assets, $230 M was left over as free cash.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

FY25: operating cash $276 M against profit $47.0 M; 130% of 3 years' profit came in as cash

  • Operating cash $276 M
  • Net profit $47.0 M
  • Free cash $230 M
FY25: operating cash $276 M against profit $47.0 M; 130% of 3 years' profit came in as cash
QuarterOperating cashNet profitFree cash
FY21$362 M$341 M$307 M
FY22$183 M$243 M$107 M
FY23$276 M−$100 M$218 M
FY24$337 M−$1.1 B$303 M
FY25$276 M$47.0 M$230 M
Operating cash flow and net profit each year, $ B. The line is free cash flow: operating cash minus spending on assets. 5-year window, yearly figures.

Jul 2026: operating cash $119 M = 222% of the quarter's profit

  • Operating cash (quarterly) $119 M
Jul 2026: operating cash $119 M = 222% of the quarter's profit
QuarterOperating cash (quarterly)
Sep 2023$95.5 M
Dec 2023$102 M
Mar 2024$40.3 M
Jun 2024$93.1 M
Sep 2024$70.7 M
Dec 2024$132 M
Mar 2025$0.3 M
Jun 2025$88.7 M
Sep 2025$78.7 M
Dec 2025$108 M
Apr 2026−$3.3 M
Jul 2026$119 M

Operating cash as % of profit

  • Operating cash as % of profit 222%
Operating cash as % of profit
QuarterOperating cash as % of profit
Sep 2023444%
Dec 2023–
Mar 2024171%
Jun 2024–
Sep 2024862%
Dec 202411,033%
Mar 20252%
Jun 2025336%
Sep 2025–
Dec 2025328%
Apr 2026−9%
Jul 2026222%
Top: operating cash each quarter, $ M. Below: operating cash as a % of net profit; 100% means all of the quarter's profit came in as cash. Last 12 quarters.

Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason.

What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building.

Where does Envista Holdings' cash go?

Envista Holdings Corporation does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $137 M on assets over the last 3 years. Averaged over those years that is 1.7% of FY25 revenue a year.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn.

Spending on assets: $137 M over the last 3 years.

FY25: capex $45.3 M, steady spending

  • Capex $45.3 M
FY25: capex $45.3 M, steady spending
QuarterCapex
FY21$54.7 M
FY22$75.7 M
FY23$58.2 M
FY24$33.8 M
FY25$45.3 M
Capital spending each year, $ M.

Jul 2026: capex $14.9 M in the quarter

  • Capex (quarterly) $14.9 M
Jul 2026: capex $14.9 M in the quarter
QuarterCapex (quarterly)
Sep 2023$18.4 M
Dec 2023$8.2 M
Mar 2024$11.0 M
Jun 2024$6.8 M
Sep 2024$7.4 M
Dec 2024$8.6 M
Mar 2025$5.9 M
Jun 2025$12.3 M
Sep 2025$10.8 M
Dec 2025$16.3 M
Apr 2026$12.5 M
Jul 2026$14.9 M

Free cash

  • Free cash $104 M
Free cash
QuarterFree cash
Sep 2023$77.1 M
Dec 2023$93.8 M
Mar 2024$29.3 M
Jun 2024$86.3 M
Sep 2024$63.3 M
Dec 2024$124 M
Mar 2025−$5.6 M
Jun 2025$76.4 M
Sep 2025$67.9 M
Dec 2025$91.7 M
Apr 2026−$15.8 M
Jul 2026$104 M
Top: capital spending each quarter, $ M. Below: free cash flow, $ M. Last 12 quarters.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

What is Envista Holdings' P/E ratio, and how does it compare with its own history?

Envista Holdings Corporation's P/E is 7.1×, with too little history to compare. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many dollars the market pays for each dollar of yearly profit.

P/E 7.1× against a usual —: with too little history to compare

  • P/E 47.0×
P/E 7.1× against a usual —: with too little history to compare
WeekP/E
1 Jul 202223.9×
8 Jul 202223.8×
15 Jul 202223.6×
22 Jul 202223.9×
29 Jul 202224.8×
5 Aug 202225.0×
12 Aug 202225.3×
19 Aug 202223.5×
26 Aug 202222.3×
2 Sep 202221.8×
9 Sep 202223.1×
16 Sep 202220.9×
23 Sep 202221.1×
30 Sep 202222.3×
7 Oct 202222.6×
14 Oct 202222.3×
21 Oct 202222.9×
28 Oct 202222.6×
4 Nov 202223.4×
11 Nov 202225.8×
18 Nov 202225.0×
25 Nov 202225.2×
2 Dec 202223.7×
9 Dec 202222.3×
16 Dec 202222.4×
23 Dec 202222.5×
30 Dec 202222.9×
6 Jan 202324.0×
13 Jan 202326.0×
20 Jan 202326.9×
27 Jan 202328.0×
3 Feb 202330.1×
10 Feb 202329.1×
17 Feb 202328.1×
24 Feb 202327.9×
3 Mar 202329.0×
10 Mar 202327.3×
17 Mar 202327.4×
24 Mar 202327.9×
31 Mar 202333.9×
6 Apr 202331.9×
14 Apr 202331.3×
21 Apr 202332.3×
28 Apr 202331.9×
5 May 202329.3×
12 May 202327.4×
19 May 202329.4×
26 May 202327.6×
2 Jun 202327.4×
9 Jun 202326.4×
16 Jun 202327.8×
23 Jun 202327.8×
30 Jun 202327.5×
7 Jul 202327.4×
14 Jul 202328.5×
21 Jul 202328.7×
28 Jul 202328.2×
4 Aug 202327.4×
11 Aug 202327.1×
18 Aug 202326.6×
25 Aug 202326.4×
1 Sep 202326.3×
8 Sep 202324.3×
15 Sep 202323.5×
22 Sep 202322.6×
29 Sep 202325.8×
6 Oct 202324.4×
13 Oct 202322.4×
20 Oct 202322.9×
27 Oct 202321.8×
3 Nov 202320.4×
10 Nov 202319.9×
17 Nov 202321.7×
24 Nov 202322.3×
1 Dec 202322.1×
8 Dec 202321.7×
15 Dec 202322.1×
22 Dec 202322.4×
29 Dec 202322.3×
5 Jan 202421.6×
12 Jan 202422.4×
19 Jan 202421.9×
26 Jan 202422.5×
2 Feb 202422.0×
9 Feb 202420.3×
16 Feb 202420.8×
23 Feb 202420.9×
1 Mar 202419.4×
8 Mar 202419.6×
15 Mar 202419.8×
22 Mar 202419.7×
28 Mar 202419.8×
5 Apr 202418.9×
12 Apr 202417.7×
19 Apr 202418.5×
26 Apr 202418.9×
3 May 202417.6×
27 Jun 202563.5×
3 Jul 202565.8×
11 Jul 202565.2×
18 Jul 202562.9×
25 Jul 202567.1×
1 Aug 202567.2×
8 Aug 202565.3×
15 Aug 202566.6×
22 Aug 202570.1×
29 Aug 202568.3×
5 Sep 202568.7×
12 Sep 202567.8×
19 Sep 202567.5×
26 Sep 2025254.4×
3 Oct 2025260.6×
10 Oct 2025238.3×
17 Oct 2025249.5×
24 Oct 2025254.5×
31 Oct 2025254.4×
7 Nov 2025243.1×
14 Nov 2025242.5×
21 Nov 2025248.6×
28 Nov 2025261.3×
5 Dec 2025252.9×
12 Dec 2025261.3×
19 Dec 2025261.3×
26 Dec 2025261.3×
2 Jan 202679.2×
9 Jan 202686.2×
16 Jan 202692.1×
23 Jan 202687.0×
30 Jan 202685.7×
6 Feb 2026106.2×
13 Feb 2026105.7×
20 Feb 2026106.3×
27 Feb 2026106.6×
6 Mar 202698.0×
13 Mar 202689.8×
20 Mar 202690.8×
27 Mar 202689.8×
2 Apr 202694.2×
10 Apr 202665.3×
17 Apr 202668.9×
24 Apr 202666.3×
1 May 202665.2×
8 May 202660.0×
15 May 202657.5×
22 May 202658.0×
29 May 202658.3×
5 Jun 202657.2×
12 Jun 202660.9×
18 Jun 202664.1×
26 Jun 202666.7×
2 Jul 202668.4×
10 Jul 202644.8×
17 Jul 202646.3×
24 Jul 202645.5×
31 Jul 202647.3×
7 Aug 202648.7×
14 Aug 202648.6×
21 Aug 202647.1×
28 Aug 202646.9×
4 Sep 202647.2×
11 Sep 202644.2×
18 Sep 202640.4×
25 Sep 202641.4×
2 Oct 202640.6×
9 Oct 202639.8×
16 Oct 202639.6×
23 Oct 202640.8×
30 Oct 202640.7×
4 Nov 202647.0×

Earnings per share, 12 months

  • Earnings per share, 12 months $0.58
Earnings per share, 12 months
WeekEarnings per share, 12 months
1 Jul 2022–
8 Jul 2022–
15 Jul 2022–
22 Jul 2022–
29 Jul 2022–
5 Aug 2022–
12 Aug 2022–
19 Aug 2022–
26 Aug 2022–
2 Sep 2022–
9 Sep 2022–
16 Sep 2022–
23 Sep 2022–
30 Sep 2022$1.47
7 Oct 2022$1.47
14 Oct 2022$1.47
21 Oct 2022$1.47
28 Oct 2022$1.47
4 Nov 2022$1.47
11 Nov 2022$1.47
18 Nov 2022$1.47
25 Nov 2022$1.47
2 Dec 2022$1.47
9 Dec 2022$1.47
16 Dec 2022$1.47
23 Dec 2022$1.47
30 Dec 2022$1.47
6 Jan 2023$1.47
13 Jan 2023$1.47
20 Jan 2023$1.47
27 Jan 2023$1.47
3 Feb 2023$1.47
10 Feb 2023$1.47
17 Feb 2023$1.47
24 Feb 2023$1.47
3 Mar 2023$1.47
10 Mar 2023$1.47
17 Mar 2023$1.47
24 Mar 2023$1.47
31 Mar 2023$1.21
6 Apr 2023$1.21
14 Apr 2023$1.21
21 Apr 2023$1.21
28 Apr 2023$1.21
5 May 2023$1.21
12 May 2023$1.21
19 May 2023$1.21
26 May 2023$1.21
2 Jun 2023$1.21
9 Jun 2023$1.21
16 Jun 2023$1.21
23 Jun 2023$1.21
30 Jun 2023$1.23
7 Jul 2023$1.23
14 Jul 2023$1.23
21 Jul 2023$1.23
28 Jul 2023$1.23
4 Aug 2023$1.23
11 Aug 2023$1.23
18 Aug 2023$1.23
25 Aug 2023$1.23
1 Sep 2023$1.23
8 Sep 2023$1.23
15 Sep 2023$1.23
22 Sep 2023$1.23
29 Sep 2023$1.08
6 Oct 2023$1.08
13 Oct 2023$1.08
20 Oct 2023$1.08
27 Oct 2023$1.08
3 Nov 2023$1.08
10 Nov 2023$1.08
17 Nov 2023$1.08
24 Nov 2023$1.08
1 Dec 2023$1.08
8 Dec 2023$1.08
15 Dec 2023$1.08
22 Dec 2023$1.08
29 Dec 2023$1.08
5 Jan 2024$1.08
12 Jan 2024$1.08
19 Jan 2024$1.08
26 Jan 2024$1.08
2 Feb 2024$1.08
9 Feb 2024$1.08
16 Feb 2024$1.08
23 Feb 2024$1.08
1 Mar 2024$1.08
8 Mar 2024$1.08
15 Mar 2024$1.08
22 Mar 2024$1.08
28 Mar 2024$1.08
5 Apr 2024$1.08
12 Apr 2024$1.08
19 Apr 2024$1.08
26 Apr 2024$1.08
3 May 2024$1.08
27 Jun 2025$0.31
3 Jul 2025$0.31
11 Jul 2025$0.31
18 Jul 2025$0.31
25 Jul 2025$0.31
1 Aug 2025$0.31
8 Aug 2025$0.31
15 Aug 2025$0.31
22 Aug 2025$0.31
29 Aug 2025$0.31
5 Sep 2025$0.31
12 Sep 2025$0.31
19 Sep 2025$0.31
26 Sep 2025$0.08
3 Oct 2025$0.08
10 Oct 2025$0.08
17 Oct 2025$0.08
24 Oct 2025$0.08
31 Oct 2025$0.08
7 Nov 2025$0.08
14 Nov 2025$0.08
21 Nov 2025$0.08
28 Nov 2025$0.08
5 Dec 2025$0.08
12 Dec 2025$0.08
19 Dec 2025$0.08
26 Dec 2025$0.08
2 Jan 2026$0.08
9 Jan 2026$0.08
16 Jan 2026$0.08
23 Jan 2026$0.08
30 Jan 2026$0.08
6 Feb 2026$0.08
13 Feb 2026$0.08
20 Feb 2026$0.08
27 Feb 2026$0.08
6 Mar 2026$0.08
13 Mar 2026$0.08
20 Mar 2026$0.08
27 Mar 2026$0.27
2 Apr 2026$0.27
10 Apr 2026$0.27
17 Apr 2026$0.27
24 Apr 2026$0.27
1 May 2026$0.27
8 May 2026$0.27
15 May 2026$0.27
22 May 2026$0.27
29 May 2026$0.27
5 Jun 2026$0.27
12 Jun 2026$0.27
18 Jun 2026$0.27
26 Jun 2026$0.40
2 Jul 2026$0.40
10 Jul 2026$0.40
17 Jul 2026$0.40
24 Jul 2026$0.40
31 Jul 2026$0.40
7 Aug 2026$0.40
14 Aug 2026$0.40
21 Aug 2026$0.40
28 Aug 2026$0.40
4 Sep 2026$0.40
11 Sep 2026$0.40
18 Sep 2026$0.40
25 Sep 2026$0.58
2 Oct 2026$0.58
9 Oct 2026$0.58
16 Oct 2026$0.58
23 Oct 2026$0.58
30 Oct 2026$0.58
4 Nov 2026$0.58
Top: P/E each week. Below: earnings per share, trailing twelve months, a step line that moves once a quarter; 4.3 years of history; short peaks above 261× are drawn at the top edge.

PEG 1.55 at the Jul 2026 quarter end: above 1.0, so the P/E is bigger than the earnings growth rate

  • PEG 1.55×
  • PEG = 1.0 1.00×
PEG 1.55 at the Jul 2026 quarter end: above 1.0, so the P/E is bigger than the earnings growth rate
QuarterPEGPEG = 1.0
Oct 20210.80×1.00×
Dec 20210.68×1.00×
Apr 20222.48×1.00×
Jul 20221.44×1.00×
Sep 20221.23×1.00×
Dec 20221.46×1.00×
Mar 20231.93×1.00×
Jun 20231.58×1.00×
Sep 20231.48×1.00×
Dec 20233.54×1.00×
Mar 20242.31×1.00×
Jun 20242.20×1.00×
Sep 20242.20×1.00×
Dec 20242.20×1.00×
Mar 20250.78×1.00×
Jun 20250.90×1.00×
Sep 20250.73×1.00×
Dec 20250.68×1.00×
Apr 20261.69×1.00×
Jul 20261.55×1.00×
PEG each quarter: the P/E divided by the yearly growth rate of earnings. The flat line marks 1.0. Below it the P/E is smaller than the growth rate; above it the P/E is bigger. Last 20 quarters.
7.1×P/E · too little history to compare
1.22PEG · today, as reported

Where the price move came from: over 3 years the price moved +7.2% a year; about −18.8% a year came from earnings growth and about +26.0 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple.

In short: there is too little history to say whether the multiple is high or low for this company, so the earnings trend underneath matters more than the multiple.

Is the Envista Holdings business getting better or worse?

Envista Holdings Corporation's business is giving mixed signals. There is no clear direction across the growth lines, with ROCE steady at 6.0%; each line tells part of the story. This is based on 12 quarters of 3 measures, with some gaps.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Growth year by year: revenue +8.3% in FY25

  • Revenue growth 8.3%
Growth year by year: revenue +8.3% in FY25
QuarterRevenue growth
FY21–
FY222.4%
FY23−0.1%
FY24−2.2%
FY258.3%

Profit growth, EPS growth

  • Profit growth −141.2%
  • EPS growth −143.9%
Profit growth, EPS growth
QuarterProfit growthEPS growth
FY21––
FY22−28.6%−28.5%
FY23−141.2%−143.9%
FY24––
FY25––
Growth on the year before, each year, %. Top: revenue. Below: net profit and earnings per share, on their own scale because profit growth swings much more. Zero line drawn.

Three growth lines over twelve quarters: revenue accelerating

  • Revenue 11.9%
Three growth lines over twelve quarters: revenue accelerating
QuarterRevenue
Sep 20232.6%
Dec 2023−0.1%
Mar 2024−0.1%
Jun 2024−1.9%
Sep 2024−3%
Dec 2024−2.2%
Mar 2025−2.3%
Jun 20250.8%
Sep 20254.7%
Dec 20258.3%
Apr 202612.1%
Jul 202611.9%

Profit, EPS

  • Profit 103.4%
  • EPS 86.4%
Profit, EPS
QuarterProfitEPS
Sep 2023−54.8%−26.4%
Dec 2023−300%−144.3%
Mar 2024−46.1%−159.7%
Jun 2024−300%−300%
Sep 2024−61.9%−300%
Dec 2024––
Mar 2025−23.7%–
Jun 2025––
Sep 2025−300%–
Dec 2025300%–
Apr 2026115%–
Jul 2026103.4%86.4%
Growth on a year earlier, % at each quarter end. Top: revenue. Below: profit and earnings per share, on their own scale because they swing much more. Each is measured over the last 12 months. Where the 12-month history is short, the line uses single-quarter growth instead, which is noisier; extreme jumps from a tiny base are evened out before reading. Extreme jumps from a tiny base are drawn at the edge (▲). A gap means there is no reading for that quarter.

ROCE: the return line, worked out each quarter

  • ROCE 6%
ROCE: the return line, worked out each quarter
QuarterROCE
Sep 20237%
Dec 2023–
Mar 2024–
Jun 2024–
Sep 2024–
Dec 2024–
Mar 2025–
Jun 20253.8%
Sep 20254.7%
Dec 20255.3%
Apr 20265.7%
Jul 20266%
Operating profit over the last 12 months (before interest and tax) as a share of average capital employed (total assets minus current liabilities), %.
FlatRevenue growth · latest +11.9%, range −3.0% to +12.1%
FlatProfit growth · latest +103.4%, range −100.0% to +100.0%
Stuck lowROCE · latest 6.0%, range 3.8% to 7.0%

Why it matters: when the lines disagree, each line above matters more than any single label.

One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result.

This reading has some gaps: at least one line is short, or the return line is not the quarterly series, so treat it with a little more caution.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the stock price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Compound annual growth rate (%)
Measure1yr3yr5yr10yr
Revenue+8.3%+1.9%——
Profit—−42.2%——
EPS—−41.1%——
Stock price+39.8%+7.2%−8.9%—
+7.1%Revenue growth (Jul 2026) · latest quarter against a year ago
+103.4%Profit growth (Jul 2026) · latest quarter against a year ago
2.0%Revenue, 4 years · yearly growth over the long run

How much does Envista Holdings earn on its capital?

Envista Holdings Corporation earned a ROE of 2% in FY25. That is up from a low of −38% in FY24. Its return on capital used (ROIC) is 1.2 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 1.7% net margin and 0.48× asset turnover (sales divided by assets).

Return on equity (ROE) is the profit the business earns on its shareholders’ money. We do not have the full capital split, so ROE is the longest history we can draw here.

Why the return is what it is (FY25): a 1.7% net margin × 0.48× asset turnover × 1.83× leverage (assets divided by equity) ≈ 1.5% on equity. The margin does its share; borrowing is a big part of it.

The key test, return on capital used minus the cost of capital: 8.7% − 7.5% = +1.2 percentage points. The 7.5% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Positive but thin: it creates value with little room for error.

The 8.7% ROIC above is the latest reading, as reported. The yearly chart below shows FY25 at 1.9%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method.

FY25: ROE 2%, the climb back from FY24's −38%

  • ROE 1.5%
  • ROIC (annual) 1.9%
  • Cost of capital 7.5%
FY25: ROE 2%, the climb back from FY24's −38%
QuarterROEROIC (annual)Cost of capital
FY218.4%8%7.5%
FY225.8%6.3%7.5%
FY23−2.4%6.5%7.5%
FY24−38.1%3.5%7.5%
FY251.5%1.9%7.5%
Return on equity each year, % (line); ROIC each year, % (line). 5-year window, low years included. The flat line is the 7.5% cost of capital used on this page.

Jul 2026: ROIC 1.5% (last 12 months) against a 7.5% cost of capital

  • ROIC (12 months) 1.5%
  • ROE (12 months) 5%
  • Cost of capital 7.5%
Jul 2026: ROIC 1.5% (last 12 months) against a 7.5% cost of capital
QuarterROIC (12 months)ROE (12 months)Cost of capital
Sep 20231.3%4.8%7.5%
Dec 20231.1%2%7.5%
Mar 20241.4%−20.5%7.5%
Jun 20240.8%2.3%7.5%
Sep 20240.1%−129.4%7.5%
Dec 20240.5%1.1%7.5%
Mar 20250.1%0.2%7.5%
Jun 20250.9%2.4%7.5%
Sep 20250.9%3.4%7.5%
Dec 2025−1.1%−3.9%7.5%
Apr 20261.3%4.2%7.5%
Jul 20261.5%5%7.5%
ROIC and ROE over the last 12 months, each quarter, %; the flat line is the cost of capital. Last 12 quarters, lined up with the yearly figure.

Does Envista Holdings have too much debt?

Envista Holdings Corporation has total debt of $1.6 B against shareholder equity of $3.1 B as of Jul 2026, so its debt is 0.52× its equity. Year by year, that ratio went from 0.36 in FY21 to 0.51 in FY25. Keep that borrowing in mind when reading the returns on this page.

Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.

FY25: debt $1.6 B, 0.51× equity

  • Total debt $1.6 B
FY25: debt $1.6 B, 0.51× equity
QuarterTotal debt
FY21$1.5 B
FY22$1.5 B
FY23$1.7 B
FY24$1.5 B
FY25$1.6 B

Debt-to-equity

  • Debt-to-equity 0.51×
Debt-to-equity
QuarterDebt-to-equity
FY210.36×
FY220.36×
FY230.40×
FY240.53×
FY250.51×
Top: total debt each year, $ B. Below: debt-to-equity, ×. 5-year window.

Jul 2026: debt $1.6 B, debt-to-equity 0.52

  • Total debt (quarterly) $1.6 B
Jul 2026: debt $1.6 B, debt-to-equity 0.52
QuarterTotal debt (quarterly)
Sep 2023$1.6 B
Dec 2023$1.7 B
Mar 2024$1.6 B
Jun 2024$1.6 B
Sep 2024$1.6 B
Dec 2024$1.5 B
Mar 2025$1.6 B
Jun 2025$1.6 B
Sep 2025$1.6 B
Dec 2025$1.6 B
Apr 2026$1.6 B
Jul 2026$1.6 B

Debt-to-equity

  • Debt-to-equity 0.52×
Debt-to-equity
QuarterDebt-to-equity
Sep 20230.38×
Dec 20230.40×
Mar 20240.40×
Jun 20240.55×
Sep 20240.51×
Dec 20240.53×
Mar 20250.51×
Jun 20250.51×
Sep 20250.52×
Dec 20250.51×
Apr 20260.52×
Jul 20260.52×
Top: total debt each quarter, $ B. Below: debt-to-equity, ×. Last 12 quarters.

What is the Envista Holdings shareholding pattern?

6.1% of Envista Holdings Corporation's tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 3.3 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead.

There is no quarter-by-quarter list of owners here, so we look at short interest: the share of tradable shares held in short positions, which gain if the price falls.

It is a single reading at one point in time; we do not have its history.

6.1%Short interest · of the tradable float
3.3Days to cover · at typical volumes

Why it is at this level: the figure does not say who has the short positions or why, so we show the level without guessing the story.

How far is Envista Holdings from balance-sheet trouble?

For Envista Holdings Corporation, the Z-score is 1.74. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the danger zone. It estimates how far the balance sheet is from trouble; it is not a forecast of failure.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

Why it matters: a Z-score of 1.74 is inside the danger zone, so the balance sheet is a real risk.

How does Envista Holdings rank in its industry?

44.4 out of 100, rank 20 of 30 in Medical Instruments & Supplies, with 58% of the evidence available.

Envista Holdings Corporation scores 44.4 out of 100 against the 30 companies it is compared with in Medical Instruments & Supplies, ranking 20. Some evidence is missing, so the score is pulled toward the middle on purpose.

The four parts add up to the total exactly: 18.6 + 11.5 + 9.2 + 5.1 = 44.4. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.

Which companies is Envista Holdings compared with?

Envista Holdings ranks 20 of 30 Medical Instruments & Supplies companies on the 4-Factor Sector Score, with 44.4 out of 100.

  1. 1West Pharmaceutical Services, Inc.WST · breaking out · Most evidence points up · 81% evidence67.6out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 23.5/35 · Revenue 12.4% · Profit 15.8% · Operating margin change 1.6 points · 83% evidenceCapital efficiency 20.6/25 · ROCE 21.2% · Operating margin 22.5% · 76% evidenceValuation 7.0/20 · P/E 44.9× · PEG 2.65 · 65% evidenceRelative strength 16.5/20 · Lead over its industry 10.3% · Lead over S&P 500 25.3% · 1 year 50.8% · 100% evidence · 5 of 12 weeks aheadExact sum: 23.5 + 20.6 + 7 + 16.5 = 67.6 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks.
  2. 2LeMaitre Vascular, Inc.LMAT · turning · Evidence leans up · 81% evidence63.6out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 26.7/35 · Revenue 11.5% · Profit 40.4% · Operating margin change 3.9 points · 83% evidenceCapital efficiency 17.3/25 · ROCE 11.9% · Operating margin 29% · 76% evidenceValuation 14.0/20 · P/E 33.4× · PEG 0.86 · 65% evidenceRelative strength 5.6/20 · Lead over its industry -22.3% · Lead over S&P 500 -11.1% · 1 year 1.3% · 100% evidence · 1 of 12 weeks aheadExact sum: 26.7 + 17.3 + 14 + 5.6 = 63.6 · What this means: Earnings are strong; relative strength in its sector is -22.3% and the one-year return is 1.3%.
  3. 3Intuitive Surgical, Inc.ISRG · breaking out · Evidence leans up · 85% evidence61.8out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 26.8/35 · Revenue 20.4% · Profit 7.7% · Operating margin change 3 points · 95% evidenceCapital efficiency 21.4/25 · ROCE 22% · Operating margin 33.3% · 76% evidenceValuation 4.5/20 · P/E 48.6× · PEG 5.33 · 65% evidenceRelative strength 9.1/20 · Lead over its industry -13.6% · Lead over S&P 500 -1.7% · 1 year -13.8% · 100% evidence · 4 of 12 weeks aheadExact sum: 26.8 + 21.4 + 4.5 + 9.1 = 61.8 · What this means: A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value.
  4. 4AtriCure, Inc.ATRC · leader · Evidence leans up · 64% evidence58.8out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 24.2/35 · Revenue 14% · Profit — · Operating margin change 10.8 points · 62% evidenceCapital efficiency 6.1/25 · ROCE 2.2% · Operating margin 6.3% · 76% evidenceValuation 8.9/20 · P/E 134.3× · PEG — · 15% evidenceRelative strength 19.6/20 · Lead over its industry 41.7% · Lead over S&P 500 59.4% · 1 year 104.5% · 100% evidence · 12 of 12 weeks aheadExact sum: 24.2 + 6.1 + 8.9 + 19.6 = 58.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  5. 5ResMed Inc.RMD · breaking out · Evidence leans up · 81% evidence58.0out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 17.8/35 · Revenue 9.8% · Profit 8.8% · Operating margin change -3 points · 83% evidenceCapital efficiency 21.5/25 · ROCE 25.4% · Operating margin 30.9% · 76% evidenceValuation 10.2/20 · P/E 18.5× · PEG 1.91 · 65% evidenceRelative strength 8.5/20 · Lead over its industry -13.6% · Lead over S&P 500 -1.9% · 1 year -4.4% · 100% evidence · 11 of 12 weeks aheadExact sum: 17.8 + 21.5 + 10.2 + 8.5 = 58 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  6. 6Merit Medical Systems, Inc.MMSI · losing its lead · Evidence leans up · 81% evidence57.1out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 22.0/35 · Revenue 10.3% · Profit 22.7% · Operating margin change 2.2 points · 83% evidenceCapital efficiency 14.3/25 · ROCE 8.1% · Operating margin 14.5% · 76% evidenceValuation 12.7/20 · P/E 28.4× · PEG 1.22 · 65% evidenceRelative strength 8.1/20 · Lead over its industry -4.7% · Lead over S&P 500 7.8% · 1 year 3.5% · 100% evidence · 10 of 12 weeks aheadExact sum: 22 + 14.3 + 12.7 + 8.1 = 57.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  7. 7Bausch + Lomb CorporationBLCO · turning · Evidence leans up · 64% evidence56.0out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 21.4/35 · Revenue 8.8% · Profit — · Operating margin change 6.8 points · 62% evidenceCapital efficiency 7.2/25 · ROCE 3.4% · Operating margin 7.7% · 76% evidenceValuation 11.5/20 · P/E -18.5× · PEG — · 15% evidenceRelative strength 15.9/20 · Lead over its industry 1.5% · Lead over S&P 500 15.3% · 1 year 32.5% · 100% evidence · 8 of 12 weeks aheadExact sum: 21.4 + 7.2 + 11.5 + 15.9 = 56 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  8. 8Kestra Medical Technologies, Ltd.KMTS · breaking out · Evidence leans up · 64% evidence54.9out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 25.1/35 · Revenue 63.6% · Profit — · Operating margin change 27.5 points · 71% evidenceCapital efficiency 3.4/25 · ROCE -48% · Operating margin -121.6% · 76% evidenceValuation 10.0/20 · P/E — · PEG — · 0% evidenceRelative strength 16.4/20 · Lead over its industry 4.3% · Lead over S&P 500 18.1% · 1 year 16.3% · 100% evidence · 9 of 12 weeks aheadExact sum: 25.1 + 3.4 + 10 + 16.4 = 54.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  9. 9Becton, Dickinson and CompanyBDX · leader · Evidence leans up · 71% evidence51.1out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 14.2/35 · Revenue 5.8% · Profit -40.6% · Operating margin change -1.4 points · 83% evidenceCapital efficiency 13.6/25 · ROCE 7.6% · Operating margin 15.7% · 76% evidenceValuation 9.6/20 · P/E 44.3× · PEG — · 15% evidenceRelative strength 13.7/20 · Lead over its industry -1.6% · Lead over S&P 500 11.4% · 1 year 17.5% · 100% evidence · 12 of 12 weeks aheadExact sum: 14.2 + 13.6 + 9.6 + 13.7 = 51.1 · What this means: Relative strength against the index is 11.4%, and revenue and profit growth are weak.
  10. 10STAAR Surgical CompanySTAA · turning · Too little evidence to rank firmly · 58% evidence50.2out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 18.2/35 · Revenue — · Profit — · Operating margin change -15 points · 45% evidenceCapital efficiency 12.8/25 · ROCE 10.3% · Operating margin 10.9% · 76% evidenceValuation 8.6/20 · P/E 360.4× · PEG — · 15% evidenceRelative strength 10.6/20 · Lead over its industry -6.6% · Lead over S&P 500 6.8% · 1 year 2.3% · 100% evidence · 1 of 12 weeks aheadExact sum: 18.2 + 12.8 + 8.6 + 10.6 = 50.2 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose.
  11. 11Baxter International Inc.BAX · quiet · Evidence leans down · 64% evidence49.9out of 100GrowthCapitalValuationRelative
  12. 12The Cooper Companies, Inc.COO · basing · Evidence leans down · 85% evidence49.3out of 100GrowthCapitalValuationRelative
  13. 13Solventum CorporationSOLV · turning · Evidence leans down · 71% evidence48.5out of 100GrowthCapitalValuationRelative
  14. 14Avantor, Inc.AVTR · leader · Evidence leans down · 71% evidence48.3out of 100GrowthCapitalValuationRelative
  15. 15Repligen CorporationRGEN · leader · Evidence leans down · 74% evidence46.8out of 100GrowthCapitalValuationRelative
  16. 16Azenta, Inc.AZTA · leader · Evidence leans down · 64% evidence46.7out of 100GrowthCapitalValuationRelative
  17. 17Alcon Inc.ALC · turning · Evidence leans down · 61% evidence45.1out of 100GrowthCapitalValuationRelative
  18. 18Align Technology, Inc.ALGN · quiet · Evidence leans down · 81% evidence44.4out of 100GrowthCapitalValuationRelative
  19. 19AptarGroup, Inc.ATR · turning · Evidence leans down · 81% evidence44.4out of 100GrowthCapitalValuationRelative
  20. 20Envista Holdings Corporation this pageNVST · quiet · Too little evidence to rank firmly · 58% evidence44.4out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 18.6/35 · Revenue — · Profit — · Operating margin change 0.7 points · 45% evidenceCapital efficiency 11.5/25 · ROCE 6.1% · Operating margin 10.4% · 76% evidenceValuation 9.2/20 · P/E 47.3× · PEG — · 15% evidenceRelative strength 5.1/20 · Lead over its industry -10.3% · Lead over S&P 500 2.1% · 1 year 39.8% · 100% evidence · 3 of 12 weeks aheadExact sum: 18.6 + 11.5 + 9.2 + 5.1 = 44.4 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose.
  21. 21Teleflex IncorporatedTFX · turning · Evidence leans down · 71% evidence43.8out of 100GrowthCapitalValuationRelative
  22. 22Stevanato Group S.p.A.STVN · quiet · Evidence leans down · 81% evidence43.7out of 100GrowthCapitalValuationRelative
  23. 23ICU Medical, Inc.ICUI · quiet · Evidence leans down · 64% evidence38.7out of 100GrowthCapitalValuationRelative
  24. 24Medline Inc.MDLN · turning · Too little evidence to rank firmly · 51% evidence37.3out of 100GrowthCapitalValuationRelative
  25. 25DENTSPLY SIRONA Inc.XRAY · basing · Most evidence points down · 64% evidence31.7out of 100GrowthCapitalValuationRelative
  26. 26Warby Parker Inc.WRBY · quiet · Most evidence points down · 64% evidence28.7out of 100GrowthCapitalValuationRelative
  27. 27BioLife Solutions, Inc.BLFS · Too little evidence to rank firmly · 44% evidence48.0out of 100GrowthCapitalValuationRelative
  28. 28Pulse Biosciences, Inc.PLSE · leader · Too little evidence to rank firmly · 41% evidence44.5out of 100GrowthCapitalValuationRelative
  29. 29MiniMed Group, Inc.MMED · quiet · Too little evidence to rank firmly · 41% evidence39.1out of 100GrowthCapitalValuationRelative
  30. 30Alamar Biosciences, Inc.ALMR · quiet · Too little evidence to rank firmly · 28% evidence38.8out of 100GrowthCapitalValuationRelative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.

The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.

Related companies: Medical Instruments & Supplies, all 30 compared on one page.

Which companies are close to Envista Holdings in size?

Envista Holdings is the 18th largest of 38 Medical Instruments & Supplies companies on Sector Alpha by market value (scores of 4 November 2026). Just above it: Teleflex Incorporated, Merit Medical Systems, Inc. and MiniMed Group, Inc. Just below it: ICU Medical, Inc., Pulse Biosciences, Inc. and Stevanato Group S.p.A.

Medical Instruments & Supplies companies close in size

  1. Teleflex Incorporated $6.4 billion
  2. Merit Medical Systems, Inc. $5.4 billion
  3. MiniMed Group, Inc. $5.4 billion
  4. Envista Holdings Corporation $4.4 billion
  5. ICU Medical, Inc. $4.3 billion
  6. Pulse Biosciences, Inc. $4.1 billion
  7. Stevanato Group S.p.A. $3.7 billion

All 38 Medical Instruments & Supplies companies, largest first

Companies close in size in other industries

  1. Tutor Perini Corporation $4.4 billion · Engineering & Construction
  2. THOR Industries, Inc. $4.4 billion · Recreational Vehicles
  3. Envista Holdings Corporation $4.4 billion
  4. Greif, Inc. $4.4 billion · Packaging & Containers
  5. Cathay General Bancorp $4.4 billion · Banks - Regional

What else do people ask about Envista Holdings?

What were Envista Holdings's latest quarterly results?

Envista Holdings Corporation reported revenue of $731 M and net profit of $53.7 M for the Jul 2026 quarter. Revenue rose 7.1% and profit rose 103.4% compared with a year earlier. Earnings per share were $0.33.

The operating margin was 10.4%, 3.0 percentage points higher than a year earlier (as of 4 November 2026).

What is Envista Holdings's market cap?

Envista Holdings Corporation's market capitalisation is $4.4 B at a stock price of $27.19. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026).

How is Envista Holdings performing?

Envista Holdings Corporation's share price has been rising for 1 weeks. In its latest quarter, revenue rose 7.1% and profit rose 103.4% compared with a year earlier. Over the past 13 weeks it has done worse than the S&P 500, for 8 weeks running (as of 4 November 2026).

Will Envista Holdings's stock price go up?

This page does not forecast Envista Holdings Corporation's stock price. What it shows instead: the stock price is $27.19, and it has been rising for 1 weeks. Nobody can reliably say which way a price will move, and this site does not try (as of 4 November 2026).

Where is Envista Holdings in its business cycle?

Envista Holdings Corporation's FY25 operating margin was 9.0%, against a 5-year range of 5.7% to 14.8%: the middle of its own range, neither a peak nor a low. The latest quarter was 10.4%.

Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026).

What could break the Envista Holdings story?

Biggest thing to watch: the price has already been rising for 1 weeks, so timing is the risk more than the business.

On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026).

Is Envista Holdings a stock worth studying right now?

What the numbers show: Envista Holdings Corporation's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results.

Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026).

Where do these numbers come from?

Sector Alpha, written by code from the published numbers. Data as of 4 November 2026.

Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.

See the plain-text version of this page.

More lists

Every Sector Alpha list, grouped

X · Instagram · YouTube · About · Newsletter · Newsletter archive
This is research, not advice. We’re not SEBI-registered.